ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Kabra Drugs Ltd

NSE: KABRADG · BSE: 524322 · Pharmaceuticals & Biotechnology · 32 announcements

Share price
₹18.49
Market cap
₹43.84 Cr
Revenue (annual)
₹92.74 Cr
Net profit (annual)
₹4.96 Cr
P/E (TTM)
5.7×Sector 43.8×
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:51 IST BSE
Capacity Expansion

Kabra Drugs Capacity Expansion

Kabra Drugs Limited announced strategic expansion into pharmaceutical manufacturing and AI-integrated defense technologies. Key initiatives include establishing an R&D facility at Cactus TECCI Park, Chennai, and obtaining a SCOMET license. The company also appointed Mr. Alagiamanavalan as an Independent Consultant for defense projects to drive diversification and long-term value creation.

Execution
Phase 1 focusing on South India; project implementation initiated immediately